Role of 18F-fluorodeoxyglucose Positron Emission Tomography-computed Tomography in Predicting Response to Cardiac Resynchronization Therapy in Nonischemic Cardiomyopathy
Annals of African Medicine · 09.04.2026
DOI: 10.4103/aam.aam_44_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of African Medicine, online erschienen am 09.04.2026. Verfasst von Ashutosh Kumar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Kamineni Institute of Medical Sciences, Hyderabad, Telengana, India.
Abstract (Originalsprache)
Background
Despite guideline-directed selection, cardiac resynchronization therapy (CRT) fails to achieve meaningful clinical or echocardiographic improvement in 20%–40% of patients. In nonischemic cardiomyopathy, occult myocardial inflammation may represent an under-recognized determinant of CRT nonresponse. This study evaluated the role of positron emission tomography (PET)-derived myocardial uptake in predicting CRT response and arrhythmic burden.
Objectives
The objective of this study was to assess whether myocardial inflammation detected by 18F-fluorodeoxyglucose PET-computed tomography (18F-FDG PET-CT) influences response to CRT and device-detected arrhythmias in patients with nonischemic cardiomyopathy. Materials and Methods: In this prospective, single-center observational case–control study, 236 patients evaluated for CRT were screened, of whom 23 patients with nonischemic cardiomyopathy fulfilling Class I indications underwent 18F-FDG PET-CT within 12 weeks of CRT -pacemaker/CRT -defibrillator (CRT-P/CRT-D) implantation. CRT response was defined by ≥10% absolute improvement in left ventricular ejection fraction (LVEF), ≥1 New York Heart Association functional class improvement, or ≥15% improvement in functional surrogate parameters. Patients were categorized as PET-positive or PET-negative based on myocardial FDG uptake. Receiver-operating characteristic (ROC) analysis was used to determine the predictive value of PET uptake.
Results
Among 23 patients, 14 (61%) were classified as CRT responders and 9 (39%) as nonresponders. Responders were significantly younger and had a lower prevalence of atrial high-rate events and clinical congestion. Mean PET uptake was significantly lower in responders compared with nonresponders (2.1 ± 1.8 vs. 10.1 ± 3.2; P < 0.001). A PET uptake threshold ≥5 units was present in 86% of nonresponders but only 11% of responders ( P < 0.001). PET uptake demonstrated excellent predictive accuracy for CRT response (area under the curve = 0.86), with a sensitivity of 86% and specificity of 78%.
Conclusion
PET-CT provides significant incremental value beyond conventional electrical and echocardiographic criteria and may serve as a useful adjunct in refining patient selection for CRT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Kamineni Institute of Medical Sciences, Hyderabad, Telengana, India.
- Department of Pharmacology, Malla Reddy Institute of Medical Sciences, Hyderabad, Telengana, India.
- Department of Cardiology, Care Hospitals, HiTech City, Hyderabad, Telengana, India.
- Department of Pulmonology, AIG Hospitals, Hyderabad, Telengana, India.
Zitieren
APA
Kumar, A., Goru, B., Patwari, P., & Sinha, N. (2026). Role of 18F-fluorodeoxyglucose Positron Emission Tomography-computed Tomography in Predicting Response to Cardiac Resynchronization Therapy in Nonischemic Cardiomyopathy. Annals of African Medicine. https://doi.org/10.4103/aam.aam_44_26
Vancouver
Kumar A, Goru B, Patwari P, Sinha N. Role of 18F-fluorodeoxyglucose Positron Emission Tomography-computed Tomography in Predicting Response to Cardiac Resynchronization Therapy in Nonischemic Cardiomyopathy. Annals of African Medicine. 2026. doi:10.4103/aam.aam_44_26
BibTeX
@article{Kumar2026,
author = {Kumar, Ashutosh and Goru, Bhawani and Patwari, Panduranga and Sinha, Nishant},
title = {Role of 18F-fluorodeoxyglucose Positron Emission Tomography-computed Tomography in Predicting Response to Cardiac Resynchronization Therapy in Nonischemic Cardiomyopathy},
journal = {Annals of African Medicine},
year = {2026},
doi = {10.4103/aam.aam_44_26}
}
EUVIMED